Arcus Biosciences to Participate in Two Upcoming Investor Conferences | News | bakersfield.com

HAYWARD, Calif.–(BUSINESS WIRE)–Nov 19, 2024–. Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on …

Continue

Do you trust this headline?

Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positive.

88%

Media Trust Score88%

Read All

In

News